Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Oncology Spectrums: Volume 2 No. 9
1
x
$
0.00
An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis
1
x
$
30.00
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
1
x
$
0.00
An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis
1
x
$
30.00
VOL 2 No. 3 Full Issue - March 2000
1
x
$
20.00
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study
1
x
$
30.00
Takefumi Suzuki - Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
1
x
$
30.00
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
1
x
$
30.00
An Evidence Based Review of Epidurolysis for the Management of Epidural Adhesions
1
x
$
30.00
EDITOR’S LETTER: Charles B. Nemeroff, MD, PhD
1
x
$
0.00
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
1
x
$
30.00
VOL 1 No. 2 Full Issue - September 1999
1
x
$
20.00
Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors
1
x
$
30.00
View Cart
Checkout
Home
Store
“Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
$
30.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
30.00
Add to cart
Details
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
$
30.00
Add to cart
Details
Neuropsicofarmacología geriátrica: una guía sobre dosificación y monitoreo de sustancias psicotrópicas en la población geriátrica
$
0.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Neurociencias: Tipos de convulsiones, síndromes epilépticos, etiología y diagnóstico
$
0.00
Add to cart
Details
Neurociencias: Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
$
0.00
Add to cart
Details
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
$
30.00
Add to cart
Details
Negar Fani – Neuropsychological Functioning in Patients with Posttraumatic Stress Disorder Following Short-Term Paroxetine Treatment
$
30.00
Add to cart
Details
Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder
$
30.00
Add to cart
Details
Naldemedine for the Use of Management of Opioid Induced Constipation
$
30.00
Add to cart
Details
Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Add to cart
Details
Previous
1
…
19
20
21
…
44
Next
Page load link
Go to Top
